The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer

Sara Sheikhbahaei, Esther Mena, Anusha Yanamadala, Siddaling Reddy, Lilja Solnes, Jason Wachsmann, Rathan M. Subramaniam

Research output: Contribution to journalReview article

Abstract

OBJECTIVE. The purpose of this article is to summarize the evidence regarding the role of FDG PET/CT in treatment response assessment and surveillance of lung cancer and to provide suggested best practices. CONCLUSION. FDG PET/CT is a valuable imaging tool for assessing treatment response for patients with lung cancer, though evidence for its comparative effectiveness with chest CT is still evolving. FDG PET/CT is most useful when there is clinical suspicion or other evidence for disease recurrence or metastases. The sequencing, cost analysis, and comparative effectiveness of FDG PET/CT and conventional imaging modalities in the follow-up setting need to be investigated.

Original languageEnglish (US)
Pages (from-to)420-433
Number of pages14
JournalAmerican Journal of Roentgenology
Volume208
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

Lung Neoplasms
Practice Guidelines
Cost-Benefit Analysis
Thorax
Neoplasm Metastasis
Recurrence
Therapeutics

Keywords

  • FDG PET/CT
  • Follow-up
  • Lung cancer
  • Recurrence detection
  • Therapy assessment

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer. / Sheikhbahaei, Sara; Mena, Esther; Yanamadala, Anusha; Reddy, Siddaling; Solnes, Lilja; Wachsmann, Jason; Subramaniam, Rathan M.

In: American Journal of Roentgenology, Vol. 208, No. 2, 01.02.2017, p. 420-433.

Research output: Contribution to journalReview article

Sheikhbahaei, S, Mena, E, Yanamadala, A, Reddy, S, Solnes, L, Wachsmann, J & Subramaniam, RM 2017, 'The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer', American Journal of Roentgenology, vol. 208, no. 2, pp. 420-433. https://doi.org/10.2214/AJR.16.16532
Sheikhbahaei, Sara ; Mena, Esther ; Yanamadala, Anusha ; Reddy, Siddaling ; Solnes, Lilja ; Wachsmann, Jason ; Subramaniam, Rathan M. / The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer. In: American Journal of Roentgenology. 2017 ; Vol. 208, No. 2. pp. 420-433.
@article{cc856c2198e8468ca2f7ce334e4375d4,
title = "The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer",
abstract = "OBJECTIVE. The purpose of this article is to summarize the evidence regarding the role of FDG PET/CT in treatment response assessment and surveillance of lung cancer and to provide suggested best practices. CONCLUSION. FDG PET/CT is a valuable imaging tool for assessing treatment response for patients with lung cancer, though evidence for its comparative effectiveness with chest CT is still evolving. FDG PET/CT is most useful when there is clinical suspicion or other evidence for disease recurrence or metastases. The sequencing, cost analysis, and comparative effectiveness of FDG PET/CT and conventional imaging modalities in the follow-up setting need to be investigated.",
keywords = "FDG PET/CT, Follow-up, Lung cancer, Recurrence detection, Therapy assessment",
author = "Sara Sheikhbahaei and Esther Mena and Anusha Yanamadala and Siddaling Reddy and Lilja Solnes and Jason Wachsmann and Subramaniam, {Rathan M.}",
year = "2017",
month = "2",
day = "1",
doi = "10.2214/AJR.16.16532",
language = "English (US)",
volume = "208",
pages = "420--433",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "2",

}

TY - JOUR

T1 - The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer

AU - Sheikhbahaei, Sara

AU - Mena, Esther

AU - Yanamadala, Anusha

AU - Reddy, Siddaling

AU - Solnes, Lilja

AU - Wachsmann, Jason

AU - Subramaniam, Rathan M.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - OBJECTIVE. The purpose of this article is to summarize the evidence regarding the role of FDG PET/CT in treatment response assessment and surveillance of lung cancer and to provide suggested best practices. CONCLUSION. FDG PET/CT is a valuable imaging tool for assessing treatment response for patients with lung cancer, though evidence for its comparative effectiveness with chest CT is still evolving. FDG PET/CT is most useful when there is clinical suspicion or other evidence for disease recurrence or metastases. The sequencing, cost analysis, and comparative effectiveness of FDG PET/CT and conventional imaging modalities in the follow-up setting need to be investigated.

AB - OBJECTIVE. The purpose of this article is to summarize the evidence regarding the role of FDG PET/CT in treatment response assessment and surveillance of lung cancer and to provide suggested best practices. CONCLUSION. FDG PET/CT is a valuable imaging tool for assessing treatment response for patients with lung cancer, though evidence for its comparative effectiveness with chest CT is still evolving. FDG PET/CT is most useful when there is clinical suspicion or other evidence for disease recurrence or metastases. The sequencing, cost analysis, and comparative effectiveness of FDG PET/CT and conventional imaging modalities in the follow-up setting need to be investigated.

KW - FDG PET/CT

KW - Follow-up

KW - Lung cancer

KW - Recurrence detection

KW - Therapy assessment

UR - http://www.scopus.com/inward/record.url?scp=85010951259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010951259&partnerID=8YFLogxK

U2 - 10.2214/AJR.16.16532

DO - 10.2214/AJR.16.16532

M3 - Review article

C2 - 27726427

AN - SCOPUS:85010951259

VL - 208

SP - 420

EP - 433

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 2

ER -